Emvision Medical Devices Ltd - Asset Resilience Ratio
Emvision Medical Devices Ltd (EMV) has an Asset Resilience Ratio of 0.47% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Emvision Medical Devices Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how Emvision Medical Devices Ltd's Asset Resilience Ratio has changed over time. See EMV net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Emvision Medical Devices Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Emvision Medical Devices Ltd worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$73.65K | 0.47% |
| Total Liquid Assets | AU$73.65K | 0.47% |
Asset Resilience Insights
- Limited Liquidity: Emvision Medical Devices Ltd maintains only 0.47% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Emvision Medical Devices Ltd Industry Peers by Asset Resilience Ratio
Compare Emvision Medical Devices Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 8.60% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 9.40% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Ok Biotech Co Ltd
TW:4155 |
Medical Devices | 0.32% |
|
Promimic AB
ST:PRO |
Medical Devices | 8.62% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Annual Asset Resilience Ratio for Emvision Medical Devices Ltd (2022–2025)
The table below shows the annual Asset Resilience Ratio data for Emvision Medical Devices Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 0.47% | AU$73.65K ≈ $52.11K |
AU$15.57 Million ≈ $11.02 Million |
+0.18pp |
| 2024-06-30 | 0.30% | AU$70.94K ≈ $50.20K |
AU$23.97 Million ≈ $16.96 Million |
-2.38pp |
| 2023-06-30 | 2.68% | AU$308.44K ≈ $218.24K |
AU$11.52 Million ≈ $8.15 Million |
+0.62pp |
| 2022-06-30 | 2.06% | AU$175.12K ≈ $123.91K |
AU$8.51 Million ≈ $6.02 Million |
-- |
About Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more